Herpes simplex virus type-1 (HSV-1) initially infects mucoepithelial tissues of the eye and the orofacial region. Subsequently, the virus is retrogradely transported through the axons of the trigeminal sensory neurons. HSV-1 establishes a life-long latent infection in these neurons, during which the transcription of the viral genome is silent, except for the sequences encoding the latency-associated transcript (LAT). To determine if HSV-1 latency might affect calcitonin gene-related peptide (CGRP) expression in trigeminal sensory neurons, we transfected primary neuronal cultures of trigeminal ganglia from rat embryos with plasmids expressing LAT. In the presence of Bone Morphogenetic Protein-7 (BMP7), CGRP was expressed in 49% of sensory neurons. However, this percentage was reduced to 19% in neurons transfected with LAT expressing plasmids. We also found that transfection of the IE63 gene of varicella-zoster virus (VZV) reduced the percentage of trigeminal neurons containing CGRP. However, the observed effect of IE63 in contrast to that of LAT was completely reversed by treatment of cultures with MgCl2, which indicates that the effect of IE63 was due to increased release of CGRP from trigeminal neurons. We provide here the first evidence that HSV-1 LAT decreases the level of CGRP in trigeminal neurons. These effects may be important for reducing the neuroinflammatory response, thus protecting host neuronal cells during HSV-1 latency in trigeminal neurons. In contrast, increased release of CGRP in the presence of IE63 protein may contribute to the neuralgias associated with VZV infection.
Introduction
Herpes simplex virus type-1 (HSV-1) infection is widespread, affecting two thirds of the human population (Schillinger et al., 2004) . HSV-1 is a member of the alphaherpesvirus family that shares the ability to establish life-long latency in neurons (Cook et al., 1974) . HSV-1 infects the orofacial region and produces a selflimiting illness that usually resolves in 1 or 2 weeks following primary infection. However, HSV-1 establishes latency in the sensory neurons that supply the infected areas. The primary host cells for HSV-1 latency are the sensory neurons of the trigeminal ganglia (Bastian et al., 1972) . During HSV-1 latency in neurons, the only significantly expressed viral RNA is the latencyassociated transcript (LAT) (Stevens, 1978) . The most stable transcript of LAT is a 2.0 kb intron that is expressed exclusively in the nuclei of latently infected neurons (Wagner et al., 1988) . The role of LAT in HSV-1 latency and reactivation, and its effects on the host cells have been extensively studied. Previous work has shown that LAT can promote survival of neurons and plays a role in viral reactivation from latency (Perng et al., 2000; Thompson and Sawtell, 1997) . Varicella-zoster virus (VZV) is another member of the alphaherpesvirus family that establishes latency in dorsal root ganglia (DRG) and to a lesser extent trigeminal neurons (LaGuardia et al., 1999) .There is evidence that the expression of the IE63 protein of VZV also promotes neuronal survival (Hood et al., 2006) . However, there is currently no evidence that either LAT or IE63 affects other functional properties of the latently infected neurons. In this study, we investigated the effects of LAT and IE63 on the expression of a key neuropeptide expressed in trigeminal neurons, the calcitonin gene-related peptide (CGRP).
CGRP is a 37 amino acid peptide that is involved in a large number of biological processes including vasodilatation, edema, immunomodulation and sensitization of sensory nerve terminals (Brain and Cox, 2006) . Previous studies have shown that CGRP can modulate the immune response through inhibition of antigen presentation cell activity in Langerhans cells, and this mechanism has been found to be involved in ultraviolet radiation-induced immunosuppression (Hosoi et al., 1993; Gillardon et al., 1995) . CGRP is an active player in neurogenic inflammation, and it is believed that CGRP is involved in the pathophysiology of migraine and other facial pains (Richardson and Vasko, 2002) . Trigeminal ganglia are the primary source of the CGRP released in the cerebral vasculature (Durham et al., 2004) .
In this study, we examined the hypothesis that the expression of HSV-1 LAT and VZV IE63 may alter CGRP expression in cultured trigeminal neurons. Our data show for the first time that HSV-1 LAT decreases CGRP expression in trigeminal neurons. This
